California Omontys Attorneys for the LGBT Community
What is Omontys?
Omontys is an erythropoiesis-stimulating agent (ESA) used in the form of an injection. It helps your body produce red blood cells and thus, is used to treat anemia (a deficiency of red blood cells in the body) in patients with chronic kidney dialysis. The FDA approved this drug in March 2012. However, its use has been associated with hypersensitivity reactions, including serious, life-threatening allergic reactions. Following its approval, there had been numerous reports of allergic reactions to this drug. On February 22, 2013, the Omontys was finally discontinued. By that time, 98 adverse events were reported, and the drug was suspected in several deaths.
Overall, over 25,000 patients were using Omontys, and about 50 cases were reported to the FDA regarding hypersensitivity and severe allergic reactions caused by the drug. 5 patients have also experienced fatal reactions following only their first dose of Omontys. These numbers only reveal the cases reported to the FDA, which signifies that these numbers only reflect the minimum number of people who the drug harmed.
In addition to hypersensitivity and life-threatening allergic reactions caused by Omontys, the drug has also been associated with increased risk of heart attack or stroke.
Let a Pride Legal Attorney Help You to Receive the Compensation You Deserve
If you or a loved one has been a victim of the negative effects associated with Omontys, contact Pride Legal today. Pride Legal’s network of independent attorneys throughout Los Angeles and Southern California are committed to helping you receive the compensation you deserve. We pride ourselves on serving the members of the LGBT community.
Contact a Los Angeles Gay and Lesbian Pharmaceutical Case Attorney today for a free initial consultation.